Cathy Maes

Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study

Isabel Leroux‐Roels, François Roman, Sheron Forgus et al. · Vaccine · 2009 · 138 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2

Peter G. Kremsner, Philipp Mann, Arne Kroidl et al. · Wiener klinische Wochenschrift · 2021 · 132 citations · Full text

Veterinary Medicine, Immunology, Molecular Pharmaceutics +17

Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes

Geert Leroux‐Roels, Cathy Maes, Frédéric Clément et al. · PLoS ONE · 2013 · 77 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study

Geert Leroux‐Roels, Cathy Maes, Fien De Boever et al. · Vaccine · 2014 · 68 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women

Geert Leroux‐Roels, Cathy Maes, Julie Willekens et al. · Vaccine · 2016 · 66 citations

Veterinary Medicine, Maternal Health, Obstetrics +17